Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying--the Road to Manufacturing Scale
Abstract
In the production of several anticancer drugs, tert-butyl alcohol (TBA) is present as a co-solvent in the aqueous drug solution. In order to ascertain if TBA should be removed beforehand or if it could be retained to facilitate the freeze-drying of the drug solution, it is important to acquire both qualitative and quantitative knowledge of the variations occurring with respect to time in heat and mass transfer during the freeze-drying process. In this work, a thermodynamic model employing the UNIFAC (Dortmund) method was developed to determine the values of the currently experimentally unavailable partial vapor pressures of the binary gas mixture of water and TBA in equilibrium with their frozen solid mixtures. The results agree satisfactorily with relevant experimental measurements and indicate that TBA vapor has constantly higher pressures than water vapor and also promotes the vapor pressure of water during sublimation. The responses of the partial pressures of water and TBA vapors are found, through the analysis of their partial and total differentials, to be increasingly more sensitive to temperature change at elevated temperatures and to compositional change when the mole fraction of water in a frozen binary mixture approaches zero. The increased vapor pressures due to TBA lead to higher total pressures at the moving interface separating the dried and frozen layers, resulting in larger total pressure gradients and convective mass transfer rates in the dried layer during primary drying. But the higher total pressures reduce the magnitude of the bulk diffusivity of the gas mixture, and combined with the smaller Knudsen diffusivity of TBA, the pressures could significantly affect the competing mass transfer mechanisms during freeze-drying. The approach presented in this work could provide a general thermodynamic modeling approach for predicting the vapor pressures of multicomponent vapor mixtures in equilibrium with their multicomponent solid frozen mixtures. LAY ABSTRACT: tert-Butyl alcohol (TBA) is present as a cosolvent in a number of anticancer drug solutions. Its presence is known to affect the freeze-drying process of the drug solutions. In order to determine a better operational policy with respect to the freeze-drying process, a thermodynamic approach was developed in this work to provide the needed data of water and TBA vapors that are currently experimentally unavailable. The results agree satisfactorily with experimental measurements. They indicate that TBA vapor has constantly higher pressures than water vapor, promoting faster sublimation and generating higher total pressures at the moving interface to enhance convective mass transfer during primary drying. However, the higher total pressures also reduce the magnitude of the bulk diffusivity of the gas mixture, and combined with the smaller Knudsen diffusivity of TBA, these pressures could significantly affect the competing mass transfer mechanisms during freeze-drying. The thermodynamic method and analysis developed in this work are useful in their own physicochemical importance and also provide a necessary component for a new class of freeze-drying mathematical models. Moreover, they could provide a general modeling approach for predicting the vapor pressures of multicomponent vapor mixtures in equilibrium with their frozen solid mixtures.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The preparation of biologics solutions at a concentration of > 100 mg/ml is generally feasible today.
“The preparation of biologics solutions at a concentration of > 100 mg/ml is generally feasible today [60], which is a major step towards reducing the dosing volume.”
From Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities (2018) · cites this paper as [60]
Cites
Effect of trehalose on protein structure
Jain, N. K., & Roy, I. (2008) · Protein Science · doi:10.1002/pro.3 · Cited by 890 · see citing works
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-76643-0_9 · Cited by 657 · see citing works
Chang, L., Shepherd, D., Sun, J., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20364 · Cited by 462 · see citing works
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
Wang, Y., Fei, D., Vanderlaan, M., & Song, A. (2004) · Angiogenesis · doi:10.1007/s10456-004-8272-2 · Cited by 431 · see citing works
Maury, M., Murphy, K., Kumar, S., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.10.002 · Cited by 266 · see citing works
Development of anti-p185HER2 immunoliposomes for cancer therapy.
Park, J. W., Hong, K., Carter, P. M., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1327 · Cited by 260 · see citing works
The Effect of Operating and Formulation Variables on the Morphology of Spray-Dried Protein Particles
Maa, Y., Costantino, H. R., Nguyen, P., et al. (1997) · Pharmaceutical Development and Technology · doi:10.3109/10837459709031441 · Cited by 229 · see citing works
Self-citationAndya, J. D., Maa, Y., Costantino, H. R., Nguyen, P., Dasovich, N., Sweeney, T. D., Hsu, C. C., & Shire, S. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018805232453 · Cited by 190 · see citing works
Self-citationAndya, J. D., Hsu, C. C., & Shire, S. J. (2003) · AAPS PharmSci · doi:10.1208/ps050210 · Cited by 167 · see citing works
Costantino, H. R., Andya, J. D., Nguyen, P. T., et al. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9800679 · Cited by 167 · see citing works
Maury, M., MURPHY, K., Kumar, S., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.010 · Cited by 144 · see citing works
The Effect of Process and Formulation Variables on the Properties of Spray-dried β-Galactosidase
Broadhead, J., Rouan, S. K. E., Hau, I., et al. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03828.x · Cited by 141 · see citing works
Stabilization of IgG1 in spray-dried powders for inhalation
Schüle, S., SCHULZFADEMRECHT, T., Garidel, P., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.02.010 · Cited by 128 · see citing works
Sukumar, M., Doyle, B. L., Combs, J. L., & Pekar, A. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032993.98705.73 · Cited by 107 · see citing works
Jovanović, N., Bouchard, A., Hofland, G. W., et al. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.003 · Cited by 97 · see citing works
He, F., Woods, C. E., Trilisky, E. I., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22384 · Cited by 81 · see citing works
Bowen, M., Armstrong, N., & Maa, Y. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23324 · Cited by 72 · see citing works
Self-citationBiopharmaceutical formulations for pre-filled delivery devices
Jezek, J., Darton, N. J., Derham, B. K., Royle, N., & SIMPSON, I. A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.780023 · Cited by 72 · see citing works
Bowen, M., Turok, R., & Maa, Y. (2013) · Drying Technology · doi:10.1080/07373937.2013.796968 · Cited by 70 · see citing works
Self-citationA new collection theory of cyclone separators
Enliang, L., & Yingmin, W. (1989) · AIChE Journal · doi:10.1002/aic.690350419 · Cited by 60 · see citing works
Nony, P., Girard, P., Chabaud, S., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00098-6 · Cited by 26 · see citing works
Development of A Platform Process for the Purification of Therapeutic Monoclonal Antibodies
Li, Y., Kahn, D. W., Galperina, O., et al. (2008) · doi:10.1002/9780470444894.ch9 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs · doi:10.1007/s40259-018-0295-0 · Cited by 447 · see citing works
Jakubowska, E., & Lulek, J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102357 · Cited by 83 · see citing works
- Authors
- Gikanga, B., Turok, R., Hui, A., Bowen, M., Stauch, O. B., & Maa, Y.-F.
- Affiliations
- Roche (United States) (US)
- Venue
- PDA Journal of Pharmaceutical Science and Technology
- Publisher
- Parenteral Drug Association, Inc.
- Published
- 2015-01-01
- Volume
- 69
- Issue
- 1
- Pages
- 59-73
- ISSN
- 1079-7440 (ISSN-L)
- OpenAlex
- W2118016452
- Cited by
- 51
- References
- 22
- Citations by year
- 2026: 5 · 2024: 4 · 2023: 8 · 2022: 5 · 2021: 8 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 2
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PDA Journal of Pharmaceutical Science and Technology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
- Physical Sciences › Engineering › Biomedical Engineering › Phase Equilibria and Thermodynamics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Food Drying and Modeling
- Keywords
- monoclonal antibody formulations, spray drying, freeze-drying, tert-butanol, partial vapor pressure, UNIFAC-Dortmund, sublimation, convective mass transfer, Knudsen diffusion, primary drying, secondary drying, anticancer agents, heat and mass transfer, thermodynamic modeling, scalable fabrication
- MeSH terms
- Antibodies, Monoclonal, Arginine, Chemistry, Pharmaceutical, Drug Stability, Feasibility Studies, Freeze Drying, Particle Size, Pilot Projects, Powders, Technology, Pharmaceutical, Trehalose, Viscosity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review